We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The aim of the present study was to construct a gene-modified hepatocellular carcinoma (HCC)-specific analgesic-antitumor peptide (AGAP) expression vector regulated by the α-fetoprotein (AFP) promoter and enhancer, in order to evaluate its effect. The AFP promoter is generally used in HCC‑specific gene therapy strategies. However, this approach is limited(More)
  • 1